REGIONAL HEALTH PROPERTIES, INC RHEP revenue by segment, product and geography
In its fiscal year ending 2025-12-31, REGIONAL HEALTH PROPERTIES, INC reported revenue across 3 business segments; the largest, Healthcare Services Segment, was $36M, 67.8% of the filed sum (+219.8% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Healthcare Services Segment$36M67.8%+219.8% yoy
- Pharmacy Service$11.7M22.1%no prior
- Real Estate Segment$5.39M10.1%-23.7% yoy
Members sum to the consolidated $53.2M for this period.
- Real Estate Segment$950K57.1%+7.7% yoy
- Healthcare Services Segment$908K54.6%-225.9% yoy
- Pharmacy Service-$194K-11.7%no prior
Members sum to the consolidated $1.66M for this period.
- Health Care Patient Service$36M67.8%+219.8% yoy
- Pharmacy Revenues$11.7M22.0%no prior
- Rental Revenue$5.4M10.2%-22.9% yoy
Members sum to the consolidated $53.2M for this period.
- Healthcare Services Segment$12.7M60.1%+125.4% yoy
- Pharmacy Service$7.6M35.9%no prior
- Real Estate Services Segment$846K4.0%-45.3% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.